Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T K Jones

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Journal of Medicinal Chemistry|July 21, 1998
Preparation, resolution, and biological evaluation of 5-aryl-1, 2-dihydro-5H-chromeno[3,4-f]quinolines: potent, orally active, nonsteroidal progesterone receptor agonistsJ P Edwards, L Zhi, C L Pooley, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 1, 1996
Discovery of novel intracellular receptor modulating drugsT K Jones, C Pathirana, M E Goldman, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 1999
Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-oneJ P Edwards, R I Higuchi, D T Winn, et al.
Cardiology in the Young|March 10, 2001
Outcomes of transcatheter balloon angioplasty of obstruction in the neo-aortic arch after the Norwood operationJ Soongswang, B W McCrindle, T K Jones, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
4-Alkyl- and 3,4-dialkyl-1,2,3,4-tetrahydro-8-pyridono[5,6-g]quinolines: potent, nonsteroidal androgen receptor agonistsR I Higuchi, J P Edwards, T R Caferro, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolinesL G Hamann, D T Winn, C L Pooley, et al.
Critical Care (London, England)|May 8, 2026
Epidemiology of the acute respiratory distress syndrome and the prognostic validity of SpO2:FiO2 under the expanded Global definitionR M Bennett, K C Housel, T K Jones, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Journal of Medicinal Chemistry|July 21, 1998
Preparation, resolution, and biological evaluation of 5-aryl-1, 2-dihydro-5H-chromeno[3,4-f]quinolines: potent, orally active, nonsteroidal progesterone receptor agonistsJ P Edwards, L Zhi, C L Pooley, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 1, 1996
Discovery of novel intracellular receptor modulating drugsT K Jones, C Pathirana, M E Goldman, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 1999
Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-oneJ P Edwards, R I Higuchi, D T Winn, et al.
Cardiology in the Young|March 10, 2001
Outcomes of transcatheter balloon angioplasty of obstruction in the neo-aortic arch after the Norwood operationJ Soongswang, B W McCrindle, T K Jones, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
4-Alkyl- and 3,4-dialkyl-1,2,3,4-tetrahydro-8-pyridono[5,6-g]quinolines: potent, nonsteroidal androgen receptor agonistsR I Higuchi, J P Edwards, T R Caferro, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolinesL G Hamann, D T Winn, C L Pooley, et al.
Critical Care (London, England)|May 8, 2026
Epidemiology of the acute respiratory distress syndrome and the prognostic validity of SpO2:FiO2 under the expanded Global definitionR M Bennett, K C Housel, T K Jones, et al.
Pageof 8